Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 47 records per page: next > | last >>
pages: 1 2 3 4 5 ... 44 45 46 47 presentations: 1 to 25 of 1167
AACR Cancer Progress Report 2014: Press Conference
Opening Video
Margaret Foti, Ph.D., M.D. (h.c.)
Chief Executive Officer of the AACR
Member of the AACR Cancer Progress Report 2014 Steering Committee
Carlos L. Arteaga, MD
AACR President
Director, Center for Cancer Targeted Therapies and director, Breast Program and SPORE, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
Chair of the AACR Cancer Progress Report 2014 Steering Committee
Jack Whelan
Waldenström macroglobulenemia survivor and advocate
The Honorable Ron Barber (via video message)
U.S. representative for Arizona’s 2nd congressional district
The Honorable Michael McCaul (via video message)
U.S. representative for Texas’ 10th congressional district
Co-chair of the House Childhood Cancer Caucus
Chairman of the House Committee on Homeland Security
Jameisha (Meisha) Brown
Adult survivor of childhood Burkitt lymphoma and advocate
from AACR Cancer Progress Report 2014: Press Conference on September 17, 2014 12:00 PM-1:00 PM
Opening Ceremony
Opening Video
Charles L. Sawyers
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
Trailer for Cancer: The Emperor of All Maladies
Ken Burns
Florentine Films
Opening Remarks
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
President's Remarks
Charles L. Sawyers
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 8:15 AM-9:15 AM
Opening Ceremony
Eighth Annual AACR Team Science Award Presentation
The Duke, Hopkins, National Cancer Institute Malignant Brain Tumor Team
Duke University Medical Center, Durham, NC; John Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD; and National Cancer Institute, Bethesda, MD
from AACR Annual Meeting 2014 on April 6, 2014 8:15 AM-9:15 AM
Opening Ceremony
Eleventh Annual AACR Award for Lifetime Achievement in Cancer Research Presentation
Douglas Hanahan
Swiss Cancer Center Lausanne, Lausanne, Switzerland
from AACR Annual Meeting 2014 on April 6, 2014 8:15 AM-9:15 AM
Opening Ceremony
Recognition of the Fellows of the AACR Academy
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
from AACR Annual Meeting 2014 on April 6, 2014 8:15 AM-9:15 AM
Opening Ceremony
2014 AACR Distinguished Public Service Award Presentation
Charles L. Sawyers
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
Award Recipient (Video)
U.S. Senator Dick Durbin [D-IL]
from AACR Annual Meeting 2014 on April 6, 2014 8:15 AM-9:15 AM
Opening Ceremony
Young Champion in Cancer Research Award Presentation
Charles L. Sawyers
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
Award Recipient
Elana Simon
from AACR Annual Meeting 2014 on April 6, 2014 8:15 AM-9:15 AM
Opening Ceremony
Eighth Annual AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research Presentation
Joan S. Brugge
Harvard Medical School, Boston, MA
Award Recipient
Webster K. Cavenee
University of California at San Diego, La Jolla, CA
from AACR Annual Meeting 2014 on April 6, 2014 8:15 AM-9:15 AM
Anti-Ras Drug Discovery: Mission Impossible?
New targets on the KRAS pathway
Frank McCormick
UCSF Helen Diller Family Comp. Cancer Ctr., San Francisco, CA, United States
from AACR Annual Meeting 2014 on April 5, 2014 1:00 PM-3:00 PM
Harnessing Breakthroughs, Targeting Cures
Transcriptional and epigenetic control of tumor cells
Richard A. Young
MIT Whitehead Inst. for Biomed. Research, Cambridge, MA, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
  •  
  • Free
  • Coming soon
  • Some slides withheld
  •  
  •  
The two faces of p53: Tumor suppressor and oncogene
Carol L. Prives
Columbia Univ., New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)
Richard S. Finn
UCLA, Los Angeles, CA, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
Discussant
José Baselga
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
New lymphoma therapies based on functional and structural genomics
Louis M. Staudt
NCI-CCR, Bethesda, MD, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
Diet and cancer: Status report in 2014
Walter C. Willett
Harvard School of Public Health, Boston, MA, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Harnessing Breakthroughs, Targeting Cures
Tumor-specific immune activation: Immuno-oncology comes of age
Roger M. Perlmutter
Merck Research Laboratories, Rahway., NJ, United States
from AACR Annual Meeting 2014 on April 6, 2014 9:15 AM-12:15 PM
Novel Immune and Targeted Therapies for Hematologic Malignancies and Solid Tumors
  •  
  • Free
  • Unknown permission
    for presentation
  •  
  •  
Chairperson
Joseph Paul Eder
Yale University, New Haven, CT, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Novel Immune and Targeted Therapies for Hematologic Malignancies and Solid Tumors
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
Renier Brentjens
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Novel Immune and Targeted Therapies for Hematologic Malignancies and Solid Tumors
  •  
  • Free
  • Coming soon
  • Some slides withheld
  •  
  •  
Discussant
Carl H. June
Abramson Cancer Ctr. of Univ. of Penn., Philadelphia, PA, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Novel Immune and Targeted Therapies for Hematologic Malignancies and Solid Tumors
Clinical safety and activity in a phase I trial of AG-221, a first in class, potent inhibitor of the IDH2-mutant protein, in patients with IDH2 mutant positive advanced hematologic malignancies
Eytan Stein
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Novel Immune and Targeted Therapies for Hematologic Malignancies and Solid Tumors
Discussant
John C. Byrd
Ohio State Univ. Comp. Cancer Ctr., Columbus, OH, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Novel Immune and Targeted Therapies for Hematologic Malignancies and Solid Tumors
Antitumor activity of the anti-PD-1 monoclonal antibody MK-3475 in melanoma(MEL): Correlation of tumor PD-L1 expression with outcome
Adil I. Daud
UCSF School of Medicine, San Francisco, CA, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Novel Immune and Targeted Therapies for Hematologic Malignancies and Solid Tumors
MK-3475 (anti-PD-1 monoclonal antibody) for non-small cell lung cancer (NSCLC): Antitumor activity and association with tumor PD-L1 expression
Leena Gandhi
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Targeted Immunotherapy: Mobilizing the Immune System Against Cancer
Engineering T cells for cancer: CARs in the clinic
Carl H. June
Abramson Cancer Ctr. of Univ. of Penn., Philadelphia, PA, United States
from AACR Annual Meeting 2014 on April 7, 2014 8:15 AM-10:15 AM
Targeted Immunotherapy: Mobilizing the Immune System Against Cancer
Investigating inhibition of the CD47 "don't eat me" signal to enable tumor phagocytic removal and augmented cross presentation to T cells
Irving L. Weissman
Stanford Univ. School of Medicine, Stanford, CA, United States
from AACR Annual Meeting 2014 on April 7, 2014 8:15 AM-10:15 AM
<< first | < prev page: of 47 records per page: next > | last >>
pages: 1 2 3 4 5 ... 44 45 46 47 presentations: 1 to 25 of 1167